Synergistic Activity of Human Milk Nutrients and Infant Cognition
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Feb 11, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how adding whole eggs to the diets of breastfeeding mothers might help support their infants' brain development. The study will involve 84 breastfeeding mothers and their babies, who are 3 months old. Mothers will either eat whole eggs or just egg whites, while researchers monitor the nutrients they and their babies receive. Throughout the study, mothers will visit the lab three times over a three-month period, where they will provide milk, saliva, and blood samples. The babies will also give saliva and a small blood sample from a heel stick. At 6 months, babies will participate in memory tests, and their mothers will complete a questionnaire about their child's temperament.
To join this study, mothers need to be between 18 and 35 years old, have a healthy baby who is 12 to 15 weeks old, and not be eating enough of certain nutrients important for brain development. However, babies with developmental delays, allergies to eggs, or certain health conditions cannot participate. This trial is currently recruiting participants, and it's a great opportunity for mothers looking to contribute to research on infant nutrition and cognitive development.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • infant is 12-15 weeks of age at enrollment
- • healthy, lactating mother age 18-35
- • gave birth at \>38 weeks gestation without remarkable incident
- • consuming \<=50% of the recommended amounts of 2 of the 3, DHA, choline, and lutein
- Exclusion Criteria:
- • infant with diagnosis or documented suspicion of developmental delay
- • egg allergy or family history of egg allergy
- • gestational diabetes
- • any documented seizure activity
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kannapolis, North Carolina, United States
Patients applied
Trial Officials
Carol L Cheatham, Ph.D.
Principal Investigator
Associate Professor, University of North Carolina-Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials